Clinical manifestation of Fuchs uveitis syndrome in childhood
Related Experiment Video
Updated: Apr 17, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Christoph Tappeiner1, Jens Dreesbach, Martin Roesel
1Department of Ophthalmology, St. Franziskus Hospital, Hohenzollernring 74, 48145, Münster, Germany.
Insights
Fuchs uveitis syndrome (FUS) can start in childhood, with typical signs often appearing later. Early diagnosis is crucial to prevent complications and avoid overtreatment with anti-inflammatory drugs.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Inflammatory Eye Diseases
Background:
- Fuchs uveitis syndrome (FUS) is a chronic inflammatory eye condition.
- Early-onset FUS in children presents unique diagnostic challenges.
- Understanding FUS in pediatric populations is vital for timely management.
Purpose of the Study:
- To describe the clinical signs and complications of Fuchs uveitis syndrome (FUS) in patients with onset before age 16.
- To highlight the diagnostic delays and potential consequences in juvenile FUS.
- To inform clinical practice regarding early identification and management of FUS in children.
Main Methods:
- Retrospective analysis of ophthalmologic findings in patients diagnosed with FUS before 16 years of age.
- Inclusion criteria: pathognomonic FUS signs and exclusion of systemic diseases.
- Data collected at a tertiary referral uveitis center.
Main Results:
- 23 patients (16 male, 7 female) with juvenile FUS were analyzed.
- Common signs included anterior chamber cells, vitreous cells, and mutton-fat keratic precipitates.
- Complications like cataract (19 patients) and ocular hypertension (3 patients) developed after prolonged inflammation.
Conclusions:
- Fuchs uveitis syndrome can manifest in early childhood, often with non-specific initial signs.
- Characteristic FUS findings may appear years after disease onset, delaying diagnosis.
- Delayed diagnosis can lead to overtreatment and long-term ocular complications.
Purpose:
The aim of this study was to describe clinical signs and complications of Fuchs uveitis syndrome (FUS) with onset in childhood.
Methods:
Ophthalmologic findings and complications in patients with FUS becoming manifest before the age of 16 years were analyzed in a retrospective study at a tertiary referral uveitis center. Inclusion criteria were the presence of pathognomonic FUS findings at any time point and exclusion of any systemic immune-mediated or infectious disease.
Results:
A total of 23 patients (male = 16, female = 7) with juvenile FUS (unilateral n = 20, bilateral n = 3 patients) were included in the study. Mean ages at uveitis and FUS diagnosis were 12.0 ± 4.2 and 22.7 ± 10.7 years, respectively. In six patients, inflammation was noted at age ≤ 7 years. The following inflammatory signs were observed in a total of 26 eyes: ≤ 1+ anterior chamber cell grade (n = 26), vitreous cells (n = 24), fine keratic precipitates (KPs; n = 23), stellate KPs (n = 11), mutton-fat KPs (n = 23), diffuse (n = 24) or inferior (n = 8) distribution of KPs, Koeppe nodules (n = 10), and iris heterochromia (n = 14). A representative subgroup of patients (n = 5) is shown who presented with non-specific clinical signs in the beginning and in whom typical FUS signs became manifest only at a later stage. Secondary complications such as cataract (n = 19), ocular hypertension (n = 3), or glaucomatous disc damage (n = 2) were found after a mean uveitis duration of 11.6, 19.5, and 20.3 years, respectively.
Conclusion:
FUS may begin in early childhood, and the characteristic findings may not be present at onset of disease. The diagnosis is often delayed for years, occasionally with the consequence of overtreatment with anti-inflammatory drugs.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Photoreceptors and Visual Pathways
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management

